Articles

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis

Department of Hematology, Amsterdam University Medical Center, University of Amsterdam;Lymphoma and Myeloma Center Amsterdam-LYMMCARE, and Cancer Center Amsterdam (CCA), Amsterdam;Department of Hematology, Leiden University Medical Center, Leiden
Department of Hematology, Leiden University Medical Center, Leiden
Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden
Lymphoma and Myeloma Center Amsterdam-LYMMCARE, and Cancer Center Amsterdam (CCA), Amsterdam;Department of Pathology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam
Department of Hematology, Leiden University Medical Center, Leiden
Department of Pathology, Leiden University Medical Center, Leiden
Department of Internal Medicine & Hematology, Onze Lieve Vrouwe Gasthuis, Amsterdam
Department of Pathology, Onze Lieve Vrouwe Gasthuis, Amsterdam
Department of Internal Medicine & Hematology, Albert Schweitzer Hospital, Dordrecht
Department of Internal Medicine & Hematology, Tergooi Hospital, Hilversum
Department of Hematology, Amsterdam University Medical Center, University of Amsterdam;Department of Internal Medicine & Hematology, Deventer Hospital, Deventer
Department of Internal Medicine & Hematology, Waterland Hospital, Purmerend
Department of Medical Oncology & Hematology, Antoni van Leeuwenhoekziekenhuis, Amsterdam
Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands
Department of Pathology, Leiden University Medical Center, Leiden
Department of Hematology, Leiden University Medical Center, Leiden
Lymphoma and Myeloma Center Amsterdam-LYMMCARE, and Cancer Center Amsterdam (CCA), Amsterdam;Department of Pathology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam
Department of Pathology, Leiden University Medical Center, Leiden
Department of Hematology, Amsterdam University Medical Center, University of Amsterdam;Lymphoma and Myeloma Center Amsterdam-LYMMCARE, and Cancer Center Amsterdam (CCA), Amsterdam
Lymphoma and Myeloma Center Amsterdam-LYMMCARE, and Cancer Center Amsterdam (CCA), Amsterdam;Department of Pathology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam
Vol. 105 No. 2 (2020): February, 2020 https://doi.org/10.3324/haematol.2018.214122